AX-2025-018601
N-Acetyl Semax Amide · 10 mg declared · ChinaPeptides Co., Ltd. (QYAOBIO) · lot QYB-2501-C5179
- Report ID
- AX-2025-018601
- Compound
- N-Acetyl Semax Amide
- Compound class
- Neuroactive and cognitive peptides
- Supplier
- QYB — ChinaPeptides Co., Ltd. (QYAOBIO)
- Batch / lot
- QYB-2501-C5179
- Declared label claim
- 10mg
- Laboratory
- Janoshik Analytical
- Assay date
- 19 Jun 2025
- Submitted
- 22 Jun 2025
- Quarter
- 2025-Q2
- Submitter
- a.wojcik
- Sample provenance
- Laboratory-retained
Results
Measured against the index acceptance specification for the neuroactive and cognitive peptides class. A specification is a decision the index made; a result is a measurement. See where each threshold came from.
| Parameter | Method | Result | Unit | Index spec | |
|---|---|---|---|---|---|
| Purity | RP-HPLC, 30 min gradient, 214 nm | 99.50 | % area | ≥ 98.5 | PASS |
| Total impurities | RP-HPLC, sum of reported peaks | 0.50 | % area | ≤ 1.5 | PASS |
| Largest single impurity | RP-HPLC — des-acetyl amide (−42 Da) | 0.23 | % area | ≤ 1.00 | PASS |
| Identity — theoretical monoisotopic mass | calculated from molecular formula | 854.3806 | Da | — | NOT TESTED |
| Identity — observed monoisotopic mass | LC-MS, high resolution (ESI-TOF/QTOF) | 854.3803 | Da | — | NOT TESTED |
| Mass accuracy | observed vs theoretical | -0.3 | ppm | ± 15 | PASS |
| Total peptide content | by difference from the gravimetric mass balance | 88.16 | %w/w | — | NOT TESTED |
| Target-compound content | total peptide content × purity | 87.72 | %w/w | — | NOT TESTED |
| Gross fill (as weighed) | five-place balance, under nitrogen | 11.06 | mg | 10 mg declared | NOT TESTED |
| Recovered target peptide | gross fill × target content | 9.702 | mg | 10 mg claim | NOT TESTED |
| Recovery against label claim | recovered ÷ claim | 97.0 | % | 90.0 – 110.0 | PASS |
| Water content | Karl Fischer, coulometric, duplicate | 5.92 | % | ≤ 12.0 | PASS |
| Counter-ion (acetate) | anion-exchange ion chromatography | 4.93 | % | ≤ 10.0 | PASS |
| Residual solvent + inorganic residue | estimated — see /methods/residual-solvents-q3c/ | 0.99 | % | — | NOT TESTED |
| Endotoxin | not ordered on this submission | not determined | — | ≤ 5.0 | NOT TESTED |
| Sterility | not ordered on this submission | not determined | — | no growth | NOT TESTED |
| Appearance | visual, diffuse light, black and white background | White lyophilised cake, intact | — | white to off-white intact cake | PASS |
| Reconstitution clarity | reconstituted per submitter procedure | Clear, colourless, no visible particulates | — | clear, no visible particulates | PASS |
| pH (reconstituted, 1 mg/mL) | potentiometric, two-point calibration | 5.22 | — | 2.5 – 8.0 | PASS |
| Retention time (observed) | RP-HPLC, 30 min gradient | 7.87 | min | 7.62 ± 0.25 (normalised) | PASS |
| Peak asymmetry (10 % height) | Ph. Eur. 2.2.46 | 1.29 | — | 0.80 – 1.50 | PASS |
| Plate count, main peak | N = 5.54 (t/w½)² | 65,052 | — | ≥ 20,000 | PASS |
| Resolution to nearest impurity | vs N-acetyl semax free acid (+1 Da) | 1.74 | — | no index criterion | REPORTED |
Chromatogram and peak integration
The figure is drawn from the table. It is not an independent illustration — if a number in the table changed, the trace would change with it.
| # | Peak | RT | Area (µV·s) | % area | Δ mass (Da) |
|---|---|---|---|---|---|
| 1 | N-Acetyl Semax Amide — main peak | 7.87 | 4,836,008 | 99.50 | — |
| 2 | des-acetyl amide (−42 Da) | 7.47 | 11,179 | 0.23 | -42.011 |
| 3 | semax (des-acetyl, des-amide, −41 Da) | 7.31 | 8,263 | 0.17 | -41.027 |
| 4 | N-acetyl semax free acid (+1 Da) | 8.09 | 2,916 | 0.06 | +0.984 |
| 5 | Met sulfoxide (+16 Da) | 7.53 | 1,944 | 0.04 | +15.995 |
| Closure check — purity + Σ impurities | 100.00 | CLOSES | |||
Reporting threshold 0.05 % area. Peaks below it are not reported and are therefore excluded from the total, which overstates purity by their sum — see peak integration.
Mass spectrum and identity
Theoretical monoisotopic mass 854.3806 Da, computed from C39H54N10O10S. All ppm figures on this site are against monoisotopic values — see why that matters.
| Charge | Theoretical m/z | Observed m/z | Δ m/z | Rel. abundance (%) |
|---|---|---|---|---|
| 2+ | 428.1976 | 428.1974 | -0.0002 | 56.3 |
| 1+ | 855.3879 | 855.3876 | -0.0003 | 100.0 |
Gravimetric mass balance
Water, counter-ion, residual and total peptide content are exhaustive and mutually exclusive categories. They must account for 100 % of the cake mass. The index closes this to within 0.02 pp and the build asserts it.
| Component | Determination | %w/w of cake |
|---|---|---|
| Water | Karl Fischer | 5.92 |
| Counter-ion (acetate) | ion chromatography | 4.93 |
| Residual solvent + inorganic residue | estimated | 0.99 |
| Total peptide content | by difference | 88.16 |
| Total | 100.00 CLOSES | |
Supplier certificate, as declared
The supplier's own figures for this lot, beside the independent measurement. Divergence is assessed against the batch median, not against this single report — see rule AX-R05.
| Figure | Supplier COA | This report | Index note |
|---|---|---|---|
| Purity (% area) | 99.17 | 99.50 | divergence -0.55 pp vs batch median |
| Total impurities (% area) | 0.83 | 0.50 | |
| Largest single impurity (% area) | not stated | 0.23 | |
| Water (%) | not stated | 5.92 | |
| Counter-ion (%) | not stated | 4.93 | |
| Peptide content (%w/w) | not stated | 88.16 | |
| Endotoxin (EU/mg) | 0.40 | not determined | |
| Method stated on certificate | YES | — | column, gradient and wavelength given |
Provenance and caveats
Where a sample came from changes the weight of the evidence. The index treats it as a first-class field.
- Sample provenance
- Laboratory-retained
- Evidentiary weight
- Provenance documented, selection uncontrolled.
- Chain of custody
- Laboratory retained sample (−20 °C, 2 d since original receipt) → re-assay.
- Assay date
- 19 Jun 2025
- Submitted to the index
- 22 Jun 2025
- Laboratory
- Janoshik Analytical, Ostrava, Czechia
- Method basis
- 30 min gradient · high-resolution MS
- Verification status
- VERIFIED
Annotations 2
Signed technical comments from index contributors. Not a discussion forum — annotations question or contextualise the result, and the data team replies where a reply is warranted.
Related records
Same batch — lot QYB-2501-C5179 n=9
| Report | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|
| AX-2025-018602 | QYB-2501-C5179 | Nordanalyt | 2025-Q2 | 99.93 | 6.04 | — | Laboratory-retained | 0 | PASS |
| AX-2025-018603 | QYB-2501-C5179 | Janoshik | 2025-Q2 | 99.68 | 6.13 | 97.9 | Laboratory-retained | 0 | PASS |
| AX-2025-018604 | QYB-2501-C5179 | Kestrel | 2025-Q2 | 99.71 | 6.34 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018605 | QYB-2501-C5179 | PeptideMeter | 2025-Q2 | 99.64 | 6.32 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018606 | QYB-2501-C5179 | Kestrel | 2025-Q2 | 99.93 | 6.10 | 98.7 | Buyer-sourced | 0 | PASS |
| AX-2025-018607 | QYB-2501-C5179 | Medutest | 2025-Q2 | 99.93 | 5.93 | 102.3 | Buyer-sourced | 0 | PASS |
| AX-2025-018608 | QYB-2501-C5179 | Janoshik | 2025-Q2 | 99.72 | 6.56 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-018609 | QYB-2501-C5179 | Janoshik | 2025-Q2 | 99.93 | 6.02 | 94.2 | Buyer-sourced | 0 | PASS |
Cross-sections
| Report | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043327 | CPC | CPC-2602-D1905 | Nordanalyt | 2026-Q3 | 99.05 | 5.67 | 90.6 | Buyer-sourced | 1 | FAIL |
| AX-2026-043328 | CPC | CPC-2602-D1905 | Janoshik | 2026-Q3 | 99.49 | 6.83 | 100.9 | Supplier-supplied | 0 | PASS |
| AX-2026-043331 | CPC | CPC-2602-D1905 | Janoshik | 2026-Q3 | 99.46 | 6.22 | — | Supplier-supplied | 0 | PASS |
| AX-2026-043329 | CPC | CPC-2602-D1905 | Janoshik | 2026-Q3 | 98.56 | 5.44 | — | Buyer-sourced | 0 | PASS |
| AX-2026-043330 | CPC | CPC-2602-D1905 | Janoshik | 2026-Q3 | 98.65 | 5.70 | 91.4 | Laboratory-retained | 0 | PASS |
| AX-2026-043326 | CPC | CPC-2602-D1905 | VendorInvestigate | 2026-Q3 | 98.93 | 5.74 | 107.0 | Buyer-sourced | 0 | PASS |
| AX-2026-042484 | Homopeptide | HOMO-2603-C5267 | Janoshik | 2026-Q2 | 99.17 | 8.61 | 92.1 | Buyer-sourced | 0 | PASS |
| AX-2026-042488 | Homopeptide | HOMO-2603-C5267 | PeptideMeter | 2026-Q2 | 98.83 | 8.48 | — | Buyer-sourced | 0 | PASS |
| Report | Compound | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041471 | PT-141 (Bremelanotide) | QYB-2607-L4875 | Janoshik | 2026-Q3 | 99.72 | 3.75 | 101.7 | Buyer-sourced | 0 | PASS |
| AX-2026-041377 | Ipamorelin | QYB-2605-H3558 | Nordanalyt | 2026-Q3 | 99.93 | 4.35 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041427 | Retatrutide | QYB-2604-B4920 | PeptideMeter | 2026-Q3 | 97.93 | 2.45 | 101.7 | Buyer-sourced | 0 | PASS |
| AX-2026-041428 | Retatrutide | QYB-2604-B4920 | Janoshik | 2026-Q3 | 98.35 | 3.20 | — | Laboratory-retained | 0 | PASS |
| AX-2026-041473 | PT-141 (Bremelanotide) | QYB-2607-L4875 | PeptideMeter | 2026-Q3 | 99.58 | 3.74 | 94.4 | Buyer-sourced | 0 | PASS |
| AX-2026-041472 | PT-141 (Bremelanotide) | QYB-2607-L4875 | PeptideMeter | 2026-Q3 | 99.93 | 3.94 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041429 | Retatrutide | QYB-2604-B4920 | Medutest | 2026-Q3 | 98.53 | 2.69 | 99.8 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-041431 | Retatrutide | QYB-2604-B4920 | Janoshik | 2026-Q3 | 98.63 | 2.32 | 94.2 | Buyer-sourced | 0 | PASS |